Skip to search.
 TSX Down 0.13% TSX Ventures Up 0.28%

Amgen Inc. (AMGN)

-NasdaqGS
156.74 Up 1.19(0.77%) May 27, 4:00PM EDT
Prev Close:155.55
Open:156.20
Bid:155.86 x 200
Ask:157.00 x 300
1y Target Est:182.35
Beta:1.23787
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:155.11 - 156.88
52wk Range:130.09 - 181.81
Volume:1,364,204
Avg Vol (3m):3,186,620
Market Cap:117.75B
P/E (ttm):16.59
EPS (ttm):9.45
Div & Yield:4.00 (2.55%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
AMGNUp 0.77%117.75B
JNJUp 0.14%310.99B

Key Statistics

Forward P/E (1 yr):12.89
P/S (ttm):5.27
Ex-Dividend Date:13-May-16

Analysts

Annual EPS Est (Dec-16) :11.14
Quarterly EPS Est (Jun-16) :2.75
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):1.77

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amgen Inc., a biotechnology company, engages in discovering, developing, manufacturing, and delivering human therapeutics worldwide. It offers products for the treatment of illness in the areas of oncology/hematology, cardiovascular, inflammation,... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback